FDA v. Alliance Hippocratic Medicine
Supreme Court of the United States · March 26, 2024
Oral argument before the U.S. Supreme Court in FDA v. Alliance for Hippocratic Medicine on challenges to FDA’s 2016 and 2021 regulatory changes for mifepristone, with extended questioning on Article III standing, agency deference, safety evidence, REMS changes, and remedial scope.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No related articles available for this source.
